Market Overview:
The global stem cell therapy for multiple sclerosis market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The market growth can be attributed to factors such as the increasing prevalence of multiple sclerosis, rising awareness about stem cell therapy for multiple sclerosis, and technological advancements in the field of stem cell therapy. However, high costs associated with stem cell therapies may restrain the growth of this market during the forecast period. The global stem cell therapy for multiple sclerosis market can be segmented on the basis of type, application, and region. On the basis of application,the global market can be classified into relapsing-remittingmultiple sclerosis (RRMS), primary progressivemultiple sclerosis (PPMS), secondary progressivemultiple sclerosis (SPMS),and progressive relapsingmultiple sclerosis(PRMS). RRMS is by far most common form accounting for approximately 85%–90%of all cases diagnosed with MS; however PPMS accounts for 10%–15%.
Product Definition:
Stem cell therapy for multiple sclerosis is a treatment that uses stem cells to help repair damage caused by the disease. The importance of stem cell therapy for multiple sclerosis is that it can help improve symptoms and slow progression of the disease.
Intravenous:
Intravenous (IV) stem cell therapy for multiple sclerosis is a new treatment option that involves the infusion of young, resilient cells reprogrammed from the patient's own blood. These cells are believed to have regenerative properties and can replace damaged or destroyed brain tissue. Research studies suggest that this procedure may be able to reduce chronic inflammatory responses in patients by changing the way immune system works.
Intracerebroventricular:
It is a minimally invasive procedure that involves drilling a hole in the skull and then using an IV line to inject or withdraw fluid into or out of the brain. This helps in treating diseases such as multiple sclerosis, Parkinson’s disease, Alzheimer’s disease, etc.
Application Insights:
Based on application, the global market is segmented into primary progressive, secondary progressive, relapsings-remitting multiple sclerosis (RRMS), and secondary Progressive Multiple Sclerosis (SPMS). Primary progressive multiple sclerosis is expected to be the fastest-growing segment over the forecast period. This growth can be attributed to a high incidence rate of around 300 per million people per year globally. According to data published by WHO in 2017, around 120 million people are suffering from this condition worldwide.
The treatment of choice for primary progressive multiple sclerosis remains continuous therapy with glatiramer acetate which has shown encouraging results in clinical trials thus far. However, due to its expensive nature it has limited applications across most developing countries which prevents them from capitalizing on its full potential revenue generating capacity.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of players, high awareness levels, and availability of advanced technologies for stem cell therapy. Moreover, increasing funding by government organizations and non-profit organizations is also expected to boost regional growth over the forecast period. For instance, in March 2016 ‘The Multiple Sclerosis Society’ (TMS) announced that it has raised USD X million from individuals and foundations to fund research into multiple sclerosis treatments through TMS Research Foundation (TMRF).
Asia Pacific is expected to grow at a lucrative rate during the forecast period owing to an increase in healthcare expenditure by governments along with rising patient awareness levels regarding emerging stem cell therapies.
Growth Factors:
- Increasing incidence of multiple sclerosis
- Rising awareness about stem cell therapy for multiple sclerosis
- Growing number of stem cell therapy clinics
- Availability of government funding for stem cell research and treatment of multiple sclerosis
- Technological advancements in the field of stem cell therapy
Scope Of The Report
Report Attributes
Report Details
Report Title
Stem Cell Therapy for Multiple Sclerosis Market Research Report
By Type
Intravenous, Intracerebroventricular
By Application
Relapsing-Remitting Multiple Sclerosis (RRMS), Primary Progressive Multiple Sclerosis (PPMS), Secondary Progressive Multiple Sclerosis (SPMS), Progressive Relapsing Multiple Sclerosis (PRMS)
By Companies
American CryoStem, Athersys, Celgene Cellular Therapeutics, Cell Cure Neurosciences
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
235
Number of Tables & Figures
165
Customization Available
Yes, the report can be customized as per your need.
Global Stem Cell Therapy for Multiple Sclerosis Market Report Segments:
The global Stem Cell Therapy for Multiple Sclerosis market is segmented on the basis of:
Types
Intravenous, Intracerebroventricular
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Relapsing-Remitting Multiple Sclerosis (RRMS), Primary Progressive Multiple Sclerosis (PPMS), Secondary Progressive Multiple Sclerosis (SPMS), Progressive Relapsing Multiple Sclerosis (PRMS)
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- American CryoStem
- Athersys
- Celgene Cellular Therapeutics
- Cell Cure Neurosciences
Highlights of The Stem Cell Therapy for Multiple Sclerosis Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Intravenous
- Intracerebroventricular
- By Application:
- Relapsing-Remitting Multiple Sclerosis (RRMS)
- Primary Progressive Multiple Sclerosis (PPMS)
- Secondary Progressive Multiple Sclerosis (SPMS)
- Progressive Relapsing Multiple Sclerosis (PRMS)
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Stem Cell Therapy for Multiple Sclerosis Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Stem cell therapy is a treatment that uses stem cells to help improve the symptoms of multiple sclerosis. These cells can help reduce inflammation and restore nerve function.
Some of the major players in the stem cell therapy for multiple sclerosis market are American CryoStem, Athersys, Celgene Cellular Therapeutics, Cell Cure Neurosciences.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Stem Cell Therapy for Multiple Sclerosis Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Stem Cell Therapy for Multiple Sclerosis Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Stem Cell Therapy for Multiple Sclerosis Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Stem Cell Therapy for Multiple Sclerosis Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Stem Cell Therapy for Multiple Sclerosis Market Size & Forecast, 2018-2028
4.5.1 Stem Cell Therapy for Multiple Sclerosis Market Size and Y-o-Y Growth
4.5.2 Stem Cell Therapy for Multiple Sclerosis Market Absolute $ Opportunity
Chapter 5 Global Stem Cell Therapy for Multiple Sclerosis Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Stem Cell Therapy for Multiple Sclerosis Market Size Forecast by Type
5.2.1 Intravenous
5.2.2 Intracerebroventricular
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Stem Cell Therapy for Multiple Sclerosis Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Stem Cell Therapy for Multiple Sclerosis Market Size Forecast by Applications
6.2.1 Relapsing-Remitting Multiple Sclerosis (RRMS)
6.2.2 Primary Progressive Multiple Sclerosis (PPMS)
6.2.3 Secondary Progressive Multiple Sclerosis (SPMS)
6.2.4 Progressive Relapsing Multiple Sclerosis (PRMS)
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Stem Cell Therapy for Multiple Sclerosis Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Stem Cell Therapy for Multiple Sclerosis Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Stem Cell Therapy for Multiple Sclerosis Analysis and Forecast
9.1 Introduction
9.2 North America Stem Cell Therapy for Multiple Sclerosis Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Stem Cell Therapy for Multiple Sclerosis Market Size Forecast by Type
9.6.1 Intravenous
9.6.2 Intracerebroventricular
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Stem Cell Therapy for Multiple Sclerosis Market Size Forecast by Applications
9.10.1 Relapsing-Remitting Multiple Sclerosis (RRMS)
9.10.2 Primary Progressive Multiple Sclerosis (PPMS)
9.10.3 Secondary Progressive Multiple Sclerosis (SPMS)
9.10.4 Progressive Relapsing Multiple Sclerosis (PRMS)
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Stem Cell Therapy for Multiple Sclerosis Analysis and Forecast
10.1 Introduction
10.2 Europe Stem Cell Therapy for Multiple Sclerosis Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Stem Cell Therapy for Multiple Sclerosis Market Size Forecast by Type
10.6.1 Intravenous
10.6.2 Intracerebroventricular
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Stem Cell Therapy for Multiple Sclerosis Market Size Forecast by Applications
10.10.1 Relapsing-Remitting Multiple Sclerosis (RRMS)
10.10.2 Primary Progressive Multiple Sclerosis (PPMS)
10.10.3 Secondary Progressive Multiple Sclerosis (SPMS)
10.10.4 Progressive Relapsing Multiple Sclerosis (PRMS)
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Stem Cell Therapy for Multiple Sclerosis Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Stem Cell Therapy for Multiple Sclerosis Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Stem Cell Therapy for Multiple Sclerosis Market Size Forecast by Type
11.6.1 Intravenous
11.6.2 Intracerebroventricular
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Stem Cell Therapy for Multiple Sclerosis Market Size Forecast by Applications
11.10.1 Relapsing-Remitting Multiple Sclerosis (RRMS)
11.10.2 Primary Progressive Multiple Sclerosis (PPMS)
11.10.3 Secondary Progressive Multiple Sclerosis (SPMS)
11.10.4 Progressive Relapsing Multiple Sclerosis (PRMS)
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Stem Cell Therapy for Multiple Sclerosis Analysis and Forecast
12.1 Introduction
12.2 Latin America Stem Cell Therapy for Multiple Sclerosis Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Stem Cell Therapy for Multiple Sclerosis Market Size Forecast by Type
12.6.1 Intravenous
12.6.2 Intracerebroventricular
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Stem Cell Therapy for Multiple Sclerosis Market Size Forecast by Applications
12.10.1 Relapsing-Remitting Multiple Sclerosis (RRMS)
12.10.2 Primary Progressive Multiple Sclerosis (PPMS)
12.10.3 Secondary Progressive Multiple Sclerosis (SPMS)
12.10.4 Progressive Relapsing Multiple Sclerosis (PRMS)
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Stem Cell Therapy for Multiple Sclerosis Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Stem Cell Therapy for Multiple Sclerosis Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Stem Cell Therapy for Multiple Sclerosis Market Size Forecast by Type
13.6.1 Intravenous
13.6.2 Intracerebroventricular
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Stem Cell Therapy for Multiple Sclerosis Market Size Forecast by Applications
13.10.1 Relapsing-Remitting Multiple Sclerosis (RRMS)
13.10.2 Primary Progressive Multiple Sclerosis (PPMS)
13.10.3 Secondary Progressive Multiple Sclerosis (SPMS)
13.10.4 Progressive Relapsing Multiple Sclerosis (PRMS)
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Stem Cell Therapy for Multiple Sclerosis Market: Competitive Dashboard
14.2 Global Stem Cell Therapy for Multiple Sclerosis Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 American CryoStem
14.3.2 Athersys
14.3.3 Celgene Cellular Therapeutics
14.3.4 Cell Cure Neurosciences
